Clinical Trial Update: Efficacy of Selegiline in Negative Symptoms of Schizophrenia [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 clinical trial evaluating the efficacy of selegiline for negative symptoms in schizophrenia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Selegiline (selegiline)

Snippet

Sponsor: Tabriz University | Conditions: Schizophrenia | EARLY_Phase 1 | Status: COMPLETED